Home

Jill M. Quigley

CIK 1799780 · Sr. Advisor & Strategy Officer · last filed 2026-05-05

Jill M. Quigley is a Sr. Advisor & Strategy Officer who has filed 26 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for TERN, was dated May 5, 2026. Across all open-market trades the lifetime net is −$464.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $85.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$85.1K

Companies

3

Total Filings

26

Lifetime Open-Market Net

-$464.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Terns Pharmaceuticals, Inc. (TERN) Delisted Director 24,520 $52.95 $1.30M -$961.4K 15 2026-05-05
CMMB Director — $1.43 — $0 1 2023-06-20
PASG Chief Operating Officer 18,618 $4.57 $85.1K $496.6K 6 2021-12-10

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-05 Terns Pharmaceuticals, Inc. (TERN) Delisted Disp (D) — $0 EDGAR
2026-02-02 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2025-11-05 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed — -$214.8K EDGAR
2025-11-04 Terns Pharmaceuticals, Inc. (TERN) Delisted Notice (144) −24,520 -$344.0K EDGAR
2025-06-12 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2025-02-03 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2025-01-06 Terns Pharmaceuticals, Inc. (TERN) Delisted Notice (144) −8,760 -$50.4K EDGAR
2025-01-06 Terns Pharmaceuticals, Inc. (TERN) Delisted Sell (S) −15,000 -$86.5K EDGAR
2024-09-11 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed — -$141.0K EDGAR
2024-09-09 Terns Pharmaceuticals, Inc. (TERN) Delisted Notice (144) −8,857 -$69.2K EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.